Xl Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.91 Cr
as on 16-11-2024
- Company Age 24 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.33 Cr
as on 16-11-2024
- Satisfied Charges ₹ 12.60 Cr
as on 16-11-2024
- Revenue -7.34%
(FY 2023)
- Profit -78.08%
(FY 2023)
- Ebitda -51.60%
(FY 2023)
- Net Worth 1.92%
(FY 2023)
- Total Assets -3.82%
(FY 2023)
About Xl Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.91 Cr.
The company currently has active open charges totaling ₹7.33 Cr. The company has closed loans amounting to ₹12.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Bhargava and Rahul Bhargava serve as directors at the Company.
- CIN/LLPIN
U24239DL2000PTC104513
- Company No.
104513
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Xl Laboratories Private Limited offer?
Xl Laboratories Private Limited offers a wide range of products and services, including Nutritional Supplements, Nutritional Vitamin Supplements, Pharmaceutical Syrup, Laboratory Equipment, Hospital Laboratory Equipment, Pharmaceutical Medicine, Appetite Stimulant, Bird Food, Poultry & Animal Food, Fish Foods, Antiviral Drugs.
Who are the key members and board of directors at Xl Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Bhargava  | Director | 16-Mar-2002 | Current |
| Ashok Bhargava | Director | 11-Feb-2002 | Current |
Financial Performance of Xl Laboratories.
Xl Laboratories Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.34% decrease. The company also saw a substantial fall in profitability, with a 78.08% decrease in profit. The company's net worth moved up by a moderate rise of 1.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xl Laboratories?
In 2023, Xl Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Sep 2024 | ₹3.50 M | Open |
Others Creation Date: 04 May 2024 | ₹5.80 M | Open |
Others Creation Date: 27 Nov 2020 | ₹2.30 Cr | Open |
How Many Employees Work at Xl Laboratories?
Xl Laboratories has a workforce of 312 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xl Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xl Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
